Source:http://linkedlifedata.com/resource/pubmed/id/19282173
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2009-4-3
|
pubmed:abstractText |
Based on the beta-catenin-drived Wnt activator of bromoindirubin-3'-oxime (BIO), indirubin analogs were evaluated for beta-catenin-mediated gene expression. A novel indirubin analog, indirubin-5-nitro-3'-oxime (INO), was considered a potential activator, and structure-activity studies were conducted with indirubins. These data suggest that INO might be a novel Wnt activator and has a potential of signaling regulator in beta-catenin-mediated signaling pathways.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1464-3405
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2282-4
|
pubmed:meshHeading |
pubmed-meshheading:19282173-Cell Line,
pubmed-meshheading:19282173-Dose-Response Relationship, Drug,
pubmed-meshheading:19282173-Humans,
pubmed-meshheading:19282173-Indoles,
pubmed-meshheading:19282173-Signal Transduction,
pubmed-meshheading:19282173-Structure-Activity Relationship,
pubmed-meshheading:19282173-beta Catenin
|
pubmed:year |
2009
|
pubmed:articleTitle |
Novel small molecule activators of beta-catenin-mediated signaling pathway: structure-activity relationships of indirubins.
|
pubmed:affiliation |
College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|